Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20181970 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL)
Condition: Osteoporosis
Interventions: Drug: lasofoxifene;   Other: placebo

Indicates status has not been verified in more than two years